Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

NON-SCLEROTIC CUTANEOUS CHRONIC GRAFT-VERSUS-HOST DISEASE

Clinical trials for NON-SCLEROTIC CUTANEOUS CHRONIC GRAFT-VERSUS-HOST DISEASE explained in plain language.

Never miss a new study

Get alerted when new NON-SCLEROTIC CUTANEOUS CHRONIC GRAFT-VERSUS-HOST DISEASE trials appear

Sign up with your email to follow new studies for NON-SCLEROTIC CUTANEOUS CHRONIC GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cream tested for Hard-to-Treat skin condition in transplant patients

Disease control Ongoing

This study is testing whether a new prescription cream (ruxolitinib 1.5%) is safer and more effective than standard moisturizers for treating a specific type of skin inflammation that can occur after a stem cell transplant. About 24 participants will apply the test cream to one s…

Matched conditions: NON-SCLEROTIC CUTANEOUS CHRONIC GRAFT-VERSUS-HOST DISEASE

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 03, 2026 14:07 UTC